Imaging pain modulation in health and disease

Current Opinion in Neurology

Volumn 20, Issue 4, 2007, Pages 424-431

  Bingel, Ulrike ^a   Schoell, Eszter ^a   Büchel, Christian ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Antinociception; Functional MRI; Neuroimaging; Pain; Pain control modulation; PET

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; CARFENTANIL; KETAMINE; MU OPIATE RECEPTOR; NALTREXONE; PLACEBO;

BRAIN CORTEX; BRAIN REGION; BRAIN STEM; CLINICAL TRIAL; DRUG ACTIVITY; FRONTAL CORTEX; HUMAN; IMAGING; INFORMATION PROCESSING; IRRITABLE COLON; MEDICAL RESEARCH; NEUROIMAGING; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PAIN; PAIN ASSESSMENT; PERCEPTION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SPINAL CORD;

ANALGESICS; CENTRAL NERVOUS SYSTEM; DIAGNOSTIC IMAGING; NEUROTRANSMITTER AGENTS; NOCICEPTORS; PAIN; PAIN MEASUREMENT; PLACEBOS;

EID: 34447303057     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328259c34d     Document Type: Review

References (63)

1. Melzack R, Wall D. Textbook of pain. 4th ed. Edinburgh: Churchill Livingstone; 1999.
2. Kupers R, Faymonville ME, Laureys S. The cognitive modulation of pain: hypnosis- and placebo-induced analgesia. Prog Brain Res 2005; 150:251-269.
3. Ploghaus A, Becerra L, Borras C, Borsook D. Neural circuitry underlying pain modulation: expectation, hypnosis, placebo. Trends Cogn Sci 2003; 7:197-200.
4. Melzack R. From the gate to the neuromatrix. Pain 1999; (Suppl 6):S121-S126.
5. Millan MJ. Descending control of pain. Prog Neurobiol 2002; 66:355-474.
6. Fields HL. Pain modulation: expectation, opioid analgesia and virtual pain. Prog Brain Res 2000; 122:245-253.
7. Bantick SJ, Wise RG, Ploghaus A, et al. Imaging how attention modulates pain in humans using functional MRI. Brain 2002; 125:310-319.
8. Ploghaus A, Tracey I, Gati JS, et al. Dissociating pain from its anticipation in the human brain. Science 1999; 284:1979-1981.
9. Porro CA, Cettolo V, Francescato MP, Baraldi P. Functional activity mapping of the mesial hemispheric wall during anticipation of pain. Neuroimage 2003; 19:1738-1747.
10. Rainville P, Carrier B, Hofbauer RK, et al. Dissociation of sensory and affective dimensions of pain using hypnotic modulation. Pain 1999; 82:159-171.
11. Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia: imaging a shared neuronal network. Science 2002; 295:1737-1740.
12. Mohr C, Binkofski F, Erdmann C, et al. The anterior cingulate cortex contains distinct areas dissociating external from self-administered painful stimulation: a parametric fMRI study. Pain 2005; 114:347-357.
13. Wiech K, Kalisch R, Weiskopf N, et al. Anterolateral prefrontal cortex mediates the analgesic effect of expected and perceived control over pain. J Neurosci 2006; 26:11501-11509.
14. Valet M, Sprenger T, Boecker H, et al. Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain: an fMRI analysis. Pain 2004; 109:399-408.
15. Bingel U, Lorenz J, Schoell E, et al. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 2006; 120:8-15.
16. Benedetti F, Mayberg HS, Wager TD, et al. Neurobiological mechanisms of the placebo effect. J Neurosci 2005; 25:10390-10402.
17. Kong J, Gollub RL, Rosman IS, et al. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci 2006; 26:381-388.
18. Sarinopoulos I, Dixon GE, Short SJ, et al. Brain mechanisms of expectation associated with insula and amygdala response to aversive taste: implications for placebo. Brain Behav Immun 2006; 20:120-132.
19. Wager TD, Rilling JK, Smith EE, et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 2004; 303:1162-1167.
20. Lorenz J, Minoshima S, Casey KL. Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain 2003; 126:1079-1091.
21. Kalisch R, Wiech K, Critchley HD, et al. Anxiety reduction through detachment: subjective, physiological, and neural effects. J Cogn Neurosci 2005; 17:874-883.
22. Benedetti F, Arduino C, Costa S, et al. Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective. Pain 2006; 121:133-144. In this both scientifically and clinically very important study, the authors assessed the interaction of verum and placebo mechanisms in patients with Alzheimer's disease, and found impaired placebo responses with loss of frontal lobe function (frontal assessment battery scores) and connectivity to other brain areas. This study indicates that loss of frontal lobe-mediated expectancy mechanisms, as in Alzheimer's disease, disrupt placebo analgesia and thus makes analgesic therapies less effective.
23. Tracey I, Iannetti GD. Brainstem functional imaging in humans. Suppl Clin Neurophysiol 2006; 58:52-67. This is an excellent review on current advances of neuroimaging of the brainstem.
24. Fairhurst M, Wiech K, Dunckley P, Tracey I. Anticipatory brainstem activity predicts neural processing of pain in humans. Pain 2007; 128:101-110. This study illustrates the relevance of the modulatory influence of brainstem activity for pain processing in humans.
25. Keltner JR, Furst A, Fan C, et al. Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study. J Neurosci 2006; 26:4437-4443. A very elegant study that addresses the question of how expectancy modulates pain perception and to what extent such modulation is accompanied by activation in brain areas implicated in descending modulatory processes. This study complements previous studies of pain expectancy by showing that pain intensity expectancy acts via a modulatory network that converges with afferent nociceptive input in the nucleus cuneiformis.
26. Peyron R, Laurent B, Garcia-Larrea L. Functional imaging of brain responses to pain: a review and meta-analysis (2000). Neurophysiol Clin 2000; 30:263-288.
27. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005; 9:463-484.
28. Price DD, Craggs J, Verne GN, et al. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 2007; 127:63-72. This study investigates placebo effects in a clinical condition (irritable bowel syndrome) in combination with fMRI. This study provides evidence that active afferent inhibition of nociceptive input also occurs during placebo analgesia of clinical conditions.
29. Koyama T, McHaffie JG, Laurienti PJ, Coghill RC. The subjective experience of pain: where expectations become reality. Proc Natl Acad Sci U S A 2005; 102:12950-12955.
30. Petrovic P, Petersson KM, Ghatan PH, et al. Pain-related cerebral activation is altered by a distracting cognitive task. Pain 2000; 85:19-30.
31. Hoffman HG, Richards TL, Bills AR, et al. Using FMRI to study the neural correlates of virtual reality analgesia. CNS Spectr 2006; 11:45-51.
32. Matre D, Casey KL, Knardahl S. Placebo-induced changes in spinal cord pain processing. J Neurosci 2006; 26:559-563. An excellent behavioral study demonstrating that expectation of pain relief (placebo) significantly reduces the size of the affected skin area in a model of secondary hyperalgesia and thus proved that placebo analgesia can influence spinal cord processes.
33. Majcher K, Tomanek B, Jasinski A, et al. Simultaneous functional magnetic resonance imaging in the rat spinal cord and brain. Exp Neurol 2006; 197:458-464.
34. Stroman PW, Kornelsen J, Bergman A, et al. Noninvasive assessment of the injured human spinal cord by means of functional magnetic resonance imaging. Spinal Cord 2004; 42:59-66.
35. Lilja J, Endo T, Hofstetter C, et al. Blood oxygenation level-dependent visualization of synaptic relay stations of sensory pathways along the neuroaxis in response to graded sensory stimulation of a limb. J Neurosci 2006; 26:6330-6336. This is a methodologically groundbreaking study with respect to the research of pain. Lilja et al. have successfully conducted fMRI of the spinal cord and medulla of the rat in response to electrical stimuli and were able to functionally dissociate the spinothalamic tract and the dorsal column pathway depending on the stimulus intensity used. In addition, the authors convincingly demonstrate a neuropharmacological modulation of these signals.
36. Akil H, Watson SJ, Young E, et al. Endogenous opioids: biology and function. Annu Rev Neurosci 1984; 7:223-255.
37. Matthes HW, Maldonado R, Simonin F, et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 1996; 383:819-823.
38. Zubieta JK, Smith YR, Bueller JA, et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001; 293:311-315.
39. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet 1978; 2:654-657.
40. Benedetti F, Arduino C, Amanzio M. Somatotopic activation of opioid systems by target-directed expectations of analgesia. J Neurosci 1999; 19:3639-3648.
41. Grevert P, Albert LH, Goldstein A. Partial antagonism of placebo analgesia by naloxone. Pain 1983; 16:129-143.
42. Zubieta JK, Bueller JA, Jackson LR, et al. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci 2005; 25: 7754-7762.
43. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 1999; 19:484-494.
44. Pertwee RG. Cannabinoid receptors and pain. Prog Neurobiol 2001; 63:569-611.
45. Bingel U, Schoell E, Herken W, et al. Habituation to painful stimulation involves the antinociceptive system. Pain 2007; 25 January [Epub ahead of print].
46. Flor H, Diers M, Birbaumer N. Peripheral and electrocortical responses to painful and nonpainful stimulation in chronic pain patients, tension headache patients and healthy controls. Neurosci Lett 2004; 361:147-150.
47. Valeriani M, de Tommaso M, Restuccia D, et al. Reduced habituation to experimental pain in migraine patients: a CO(2) laser evoked potential study. Pain 2003; 105:57-64.
48. Proietti Cecchini A, Sandrini G, Fokin IV, et al. Trigeminofacial reflexes in primary headaches. Cephalalgia 2003; 23 (Suppl 1):33-41.
49. Demirci S, Savas S. The auditory event related potentials in episodic and chronic pain sufferers. Eur J Pain 2002; 6:239-244.
50. Peters ML, Schmidt AJ, Van den Hout MA. Chronic low back pain and the reaction to repeated acute pain stimulation. Pain 1989; 39:69-76.
51. Song GH, Venkatraman V, Ho KY, et al. Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls. Pain 2006; 126:79-90. This study addresses the question of whether a dysbalance in pro and antinociceptive mechanisms may underlie the pathogenesis of irritable bowel syndrome. The authors demonstrate that behavioral differences as a result of rectal stimulation between patients and controls are paralleled by differences in pain-related central responses, which can be attributed to the endogenous pain modulatory system.
52. Wilder-Smith CH, Schindler D, Lovblad K, et al. Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut 2004; 53:1595-1601.
53. Schmidt-Wilcke T, Leinisch E, Straube A, et al. Gray matter decrease in patients with chronic tension type headache. Neurology 2005; 65:1483-1486.
54. Schmidt-Wilcke T, Leinisch E, Ganssbauer S, et al. Affective components and intensity of pain correlate with structural differences in gray matter in chronic back pain patients. Pain 2006; 125:89-97.
55. Apkarian AV, Sosa Y, Sonty S, et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci 2004; 24:10410-10415.
56. Draganski B, Moser T, Lummel N, et al. Decrease of thalamic gray matter following limb amputation. Neuroimage 2006; 31:951-957.
57. Becerra L, Harter K, Gonzalez RG, Borsook D. Functional magnetic resonance imaging measures of the effects of morphine on central nervous system circuitry in opioid-naive healthy volunteers. Anesth Analg 2006; 103:208-216. This is an extensive review article reviewing the contribution of fMRI to the understanding of acute and chronic pain, the endogenous pain control systems and the evaluation of analgesic substances. Besides the comprehensive discussion of the data, key findings related to each topic are summarized in clearly laid out tables.
58. Iannetti GD, Zambreanu L, Wise RG, et al. Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. Proc Natl Acad Sci U S A 2005; 102:18195-18200.
59. Morgan V, Pickens D, Gautam S, et al. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut 2005; 54:601-607.
60. Sprenger T, Valet M, Woltmann R, et al. Imaging pain modulation by subanesthetic S-(+)-ketamine. Anesth Analg 2006; 103:729-737.
61. Schweinhardt P, Bountra C, Tracey I. Pharmacological FMRI in the development of new analgesic compounds. NMR Biomed 2006; 19:702-711. This is an excellent review on the recent advances in the development of pharmacological imaging. It provides a comprehensive background of the potential contribution of pharmacological imaging to pain research, outlines important methodological considerations that have to be consideredwhen performing phFMRI, and summarizes the results of pharmacological imaging studies available so far.
62. Coghill RC, McHaffie JG, Yen YF. Neural correlates of interindividual differences in the subjective experience of pain. Proc Natl Acad Sci U S A 2003; 100:8538-8542.
63. Zubieta JK, Heitzeg MM, Smith YR, et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003; 299: 1240-1243.